Skip to main content
HR 2115 116th Congress House Health Business records Government information and archives Health care costs and insurance Inflation and prices Prescription drugs Retail and wholesale trades

Public Disclosure of Drug Discounts Act

Introduced: October 28, 2019 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 14 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 29, 2019
Received in the Senate and Read twice and referred to the Committee on Finance.
Oct 28, 2019
The title of the measure was amended. Agreed to without objection.
Oct 28, 2019
Motion to reconsider laid on the table Agreed to without objection.
Oct 28, 2019
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)
Oct 28, 2019
Considered as unfinished business. (consideration: CR H8520-8521)
Oct 28, 2019
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 28, 2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 2115.
Oct 28, 2019
Considered under suspension of the rules. (consideration: CR H8516-8519)
Oct 28, 2019
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
May 21, 2019
Subcommittee Hearings Held.
Apr 9, 2019
Referred to the Subcommittee on Health.
Apr 8, 2019
Referred to the Subcommittee on Health.
Apr 8, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 8, 2019
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Oct 28, 2019 House · vote #586 On Motion to Suspend the Rules and Pass, as Amended Passed 403–0 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.

The bill also provides statutory authority for certain provisions of the CMS rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.

What's happening now October 29, 2019

Received in the Senate and Read twice and referred to the Committee on Finance.

 Related & companion bills 6
  • HR 19 Related bill Lower Costs, More Cures Act of 2019
  • HR 2296 Related bill More Efficient Tools to Realize Information for Consumers Act
  • HR 3408 Related bill Shop Rx Act of 2019
  • HR 3415 Related bill Real-Time Beneficiary Drug Cost Bill
  • S 3129 Related bill Lower Costs, More Cures Act of 2019
  • HR 2113 Related bill Prescription Drug STAR Act
 Bill text 3 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 5
All 5 Democratic 2 Republican 2
D
Slotkin, Elissa
Michigan · Oct 28, 2019
Taylor, Van
· Oct 28, 2019
 R
Van Drew, Jefferson
New Jersey · May 1, 2019
 R
Arrington, Jodey C.
Texas · Apr 8, 2019
 D
Boyle, Brendan F.
Pennsylvania · Apr 8, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2115/
MLA
"H.R. 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2115/.
Bluebook (legal)
H.R. 2115, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2115/.
Markdown link
[H.R. 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act](https://openamerica.io/bill/116-HR-2115/)
Report a problem